Effects of a 12-week Home-based Yoga on Bone and Cardiovascular Health
Does a 12-week Home-based Dynamic Yoga Intervention Improve Bone and Cardiovascular Health in Healthy Premenopausal Women? A Randomized Controlled Feasibility Study
1 other identifier
interventional
35
1 country
1
Brief Summary
While effects of specific exercise interventions on bone and CVD in postmenopausal women have been demonstrated and evaluated, the effects of randomized controlled exercise interventions, particularly in middle-aged premenopausal women are sparse. Therefore, it is imperative to examine the relation between behavioral interventions and bone and cardiovascular outcomes in premenopausal women as this understudied group is at high risk for the initial stages of bone loss and cardiovascular disease development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2019
CompletedFirst Submitted
Initial submission to the registry
April 10, 2020
CompletedFirst Posted
Study publicly available on registry
April 20, 2020
CompletedApril 20, 2020
April 1, 2020
5 months
April 10, 2020
April 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Change in Physical activity participation was assessed.
Participants were asked to fill out a physical activity questionnaire (BPAQ scores) Physical activity participation was estimated with the bone-specific physical activity questionnaire (BPAQ score).
BPAQ scores were collected at baseline, at 6 weeks, and after 12 weeks to see any differences throughout the intervention periods.
Change in Health history was assessed.
A health history questionnaire (HH) was utilized to examine any medical history that can affect bone and cardiovascular health.
HH questionnaires were collected at baseline, at 6 weeks, and after 12 weeks to see any changes throughout the intervention periods.
Change in menstrual history was assessed
A menstrual history questionnaire (MH) was used to determine if a participant was pregnant.
MH questionnaires were collected at baseline, at 6 weeks, and after 12 weeks to see any changes throughout the intervention periods.
Change in calcium intake was assessed
Daily calcium intake (mg/d) was estimated using a calcium intake questionnaire (CI).
CI questionnaires were collected at baseline, at 6 weeks, and after 12 weeks to see any changes throughout the intervention periods.
Change in Body Mass Index (BMI) was assessed
Height (cm) and weight (kg) were collected to calculate BMI (kg/m2).
Height and weight were collected at baseline and after 12 weeks.
Change in total fat mass was assessed
Total fat mass (g) was measured using Dual Energy-X-ray Absorptiometry.
Total fat mass was measured at baseline and after 12 weeks.
Change in bone free lean body mass was assessed
Bone free lean body mass (g) was measured using Dual Energy-X-ray Absorptiometry.
Bone free lean body mass was measured at baseline and after 12 weeks.
Change in %fat was assessed
%fat (%) was measured using Dual Energy-X-ray Absorptiometry.
%fat was measured at baseline and after 12 weeks.
Change in P1NP was assessed.
A blood draw (approximately 10 ml) was collected to investigate differences in bone formation marker (P1NP, ng/mL)
Blood draws were collected at baseline, at 6 weeks, and after 12 weeks.
Change in CTX was assessed
A blood draw (approximately 10 ml) was collected to investigate differences in bone resorption marker (CTX, ng/mL)
Blood draws were collected at baseline, at 6 weeks, and after 12 weeks.
Secondary Outcomes (1)
Change in Arterial stiffness was assessed
Arterial stiffness was collected at baseline, at 6 weeks, and after 12 weeks
Study Arms (2)
Yoga group
ACTIVE COMPARATORA certified yoga instructor led the supervised yoga session. An exercise physiologist taught how to record your Rating of Perceived Exertion to monitor their exercise intensity during the in-home yoga intervention. During the in-home yoga intervention, participants performed 30 to 50 minutes of yoga postures three to five times a week for 12 weeks.
Control group
NO INTERVENTIONIf participants were in a CON group, they did not receive the yoga intervention. Instead, they were encouraged to maintain a normal daily lifestyle monitored by the BPAQ at one-month intervals during the 12-week intervention.
Interventions
During the in-home yoga intervention, participants performed 30 to 50 minutes of yoga postures three to five times a week for 12 weeks, including 5 minutes of warm-up exercise, 15 to 30 minutes of dynamic flow yoga postures, 10 minutes of weight barring standing postures, and 5 minutes of cool-down. These in-home sessions were a repeat of what participants learned during the first week of training session at UML. We progressively increased the intensity of the home practice sessions by adding the number of sun salutation (SS) over the 12 weeks.
Eligibility Criteria
You may qualify if:
- Participants were healthy premenopausal women volunteers between the ages of 30 and 48 years.
- Participants were free of chronic back or joint problems, cardiovascular disease, non-smokers, not pregnant, not taking antihypertensive drugs or any medication that affects bone density.
- Participants didn't have regularly participated in a weight training program and yoga exercise at least 12 months prior to the study.
- Participants were medically stable, ambulatory, and capable of training.
You may not qualify if:
- Individual who were outside of the 30-48 years age range and who exceed the weight limit of the DXA (300 pounds).
- Individuals who did not have the regular menstrual cycles.
- Pregnancy or the possibility of becoming pregnant during the intervention period
- Individuals who were taking medications known to affect bone metabolism such as steroid hormones, calcitonin, or corticosteroids.
- Any persons with physical and mental disabilities preventing them from being trained, including orthopedic or arthritic problems, were not allowed to participate.
- Individuals whose radiation exposure from medical and/or research tests in the previous year exceeds the recommended regulator limit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Massachusetts
Lowell, Massachusetts, 01854, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SoJung Kim, PhD
University of Massachusetts, Lowell
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 10, 2020
First Posted
April 20, 2020
Study Start
September 19, 2018
Primary Completion
February 16, 2019
Study Completion
September 25, 2019
Last Updated
April 20, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share